Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bariatrix lawsuits

This article was originally published in The Tan Sheet

Executive Summary

Canadian nutritional bar manufacturer has filed separate lawsuits alleging Rexall Sundown, Elan Nutrition "have been and still are infringing" on Bariatrix' patent covering nutritional, confectionery bars that are high in protein. Filed in Burlington, Vt. federal court, suits claim Bariatrix has met with both firms to no avail. "Although the parties discussed the possibility of Rexall's entering into an appropriate license agreement with Bariatrix with respect to the '929 patent, such an agreement ultimately was not consummated," complaint claims. Firm seeks "preliminary and permanent injunction" against Rexall, Elan, as well as "award of damages in favor of Bariatrix...sufficient to compensate" for the patent infringement. Bars in question include Elan's Promax, Rexall's Met-Rx, Carb Solutions, Pure Protein...

You may also be interested in...



Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.

Win For Axonics As England’s NICE Says Rechargeable Neuromodulation Is Cost-Effective

Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.

Topics

UsernamePublicRestriction

Register

PS095270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel